This is the official guideline endorsed by the specialty associations involved in the care of
head and neck cancer patients in the UK. The disease itself and the treatment can have far …

Speech and swallowing are important components of health‐related quality of life following
head and neck cancer treatment. The aim of this study was to demonstrate the value of …

The prevalence and severity of dysphagia in people treated non-surgically for primary head
and neck cancer (HNC) is well documented. However, few studies have looked beyond the …

Head and neck cancer and its treatment frequently cause changes in both speech and
swallowing, which affect the patient's quality of life and ability to function in society. The …

We undertook a service evaluation to establish how oropharyngeal dysphagia is managed
in head and neck cancer patients receiving radiotherapy in the United Kingdom. A web …

Concurrent chemoradiotherapy (CCRT) for advanced head and neck cancer (HNC) is
associated with substantial early and late side effects, most notably regarding swallowing …

Impairment of swallowing function is a common multidimensional symptom complex seen in
50–75% of head and neck cancer (HNC) survivors. Although there are a number of …

Organ preservation with radiotherapy and concomitant chemotherapy has become an
accepted treatment modality in advanced head and neck cancer. Unfortunately, organ …

Regarding dysphagia evaluation, there is still a lack of a uniform 'gold-standard'for both
assessment and treatment strategies. More high-quality data, adequately controlled …

The use of radiation therapy and/or chemotherapy in advanced head and neck cancer is
increasing in popularity, driven by the notion that sparing the organs of speech and …